News
Beloved Real Housewives of Atlanta star and celebrity hairstylist, Dwight Eubanks, 64, recently revealed to his fans and the public that he was diagnosed with prostate cancer. Although his ...
A patient shares how an event about clinical trials at Moores Cancer Center brought a community together to educate and ...
Joseph Jacob, MD, discusses the promising impact of TAR-200.
The study will use a companion lipid biomarker test to identify those with a poor prognosis who are potential best responders.
A genetics research laboratory has reached a significant milestone in its efforts to recruit 1,000 volunteers for a prostate ...
Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce that, as of July 2, 2025, Pluvicto® (lutetium (177Lu) vipivotide tetraxetan injection) is publicly reimbursed in Quebec for ...
The global Radioligand Therapy (RLT) market is poised to reach US$13 billion by 2030, expanding at a ~5% CAGR over the ...
Actinium Pharmaceuticals, Inc. (NYSE:ATNM) is among the best growth stocks to invest in for the next 5 years. During the ...
Lantheus Holdings offers a compelling bull case, with PYLARIFY and DEFINITY driving valuation and strong growth prospects.
We read with great interest the published results of the RADIOSA trial by Giulia Marvaso and colleagues.1 This well designed ...
Hormone therapy for prostate cancer is aimed at reducing or eliminating the amount of testosterone in your body to slow or stop prostate cancer cells from growing and multiplying. Hormone therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results